SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹10 Cr | ₹10 Cr | ₹8.57 Cr | ₹7.09 Cr | ₹6.83 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹10 Cr |
| Mar2024 | ₹10 Cr |
| Mar2023 | ₹8.57 Cr |
| Mar2022 | ₹7.09 Cr |
| Mar2021 | ₹6.83 Cr |
How is Deferred Tax Assets / Liabilities of SAKAR HEALTHCARE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹10 Cr | 3.18 | |
| Mar2024 | ₹10 Cr | 16.94 | |
| Mar2023 | ₹8.57 Cr | 20.87 | |
| Mar2022 | ₹7.09 Cr | 3.88 | |
| Mar2021 | ₹6.83 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹829.8 Cr | -7.5% | -3.9% | 30.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,728.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,248.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,627.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,423.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,462.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -7.5% |
-3.9% |
30.6% |
| SENSEX | -1.8% |
-0.6% |
7.3% |
You may also like the below Video Courses